Introduccion a la Ley Fundamental /

Por Duerig, Guenter
Publicado em 1988

Combustion Synthesis Porous Nitinol for Biomedical Applications

Por H. Aihara, J. Zider, G. Fanton, T. Duerig
Publicado em 2019-01-01

Explaining the Transition from Diffusion Limited to Reaction Limited Surface Assembly of Molecular Species through Spatial Variations

Por Carroll, Keith M., Knoll, Armin W., Wolf, Heiko, Duerig, Urs
Publicado no Langmuir (2017)

Prostate-MRI: experience of the observer and technical conditions influence the cancer detection rate

Por Roedel, S, Blaut, S, Duerig, E, Burke, M, Paulick, R, Haroske, G, Steinbach, F, Kittner, T
Publicado no Cancer Imaging (2014)

Prostate-MRI: experience of the observer and technical conditions influence the cancer detection rate

Por Roedel, S, Blaut, S, Duerig, E, Burke, M, Paulick, R, Haroske, G, Steinbach, F, Kittner, T
Publicado no Cancer Imaging (2014)

Second messenger-mediated spatiotemporal control of protein degradation regulates bacterial cell cycle progression

Por Duerig, Anna, Abel, Sören, Folcher, Marc, Nicollier, Micael, Schwede, Torsten, Amiot, Nicolas, Giese, Bernd, Jenal, Urs
Publicado em 2009

Control of the interaction strength of photonic molecules by nanometer precise 3D fabrication

Por Rawlings, Colin D., Zientek, Michal, Spieser, Martin, Urbonas, Darius, Stöferle, Thilo, Mahrt, Rainer F., Lisunova, Yuliya, Brugger, Juergen, Duerig, Urs, Knoll, Armin W.
Publicado no Sci Rep (2017)

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial

Por Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K., Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S., Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut
Publicado no Haematologica (2016)

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial

Por Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K., Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S., Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G.H., Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut
Publicado no Haematologica (2015)